🇺🇸 FDA
Pipeline program

Oral Insulin

ORA-D-N01

Phase 2 mab completed

Quick answer

Oral Insulin for Non-Alcoholic Steatohepatitis (NASH) is a Phase 2 program (mab) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ORAMED PHARMACEUTICALS INC.
Indication
Non-Alcoholic Steatohepatitis (NASH)
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials